On pharmacy, digital, new care prevention, with Opella UK
In a new episode, Nick Linton, head of Opella UK, discusses why community pharmacy should be seen as a core part of the prevention agenda.
Newsletters and Deep Dive digital magazine
In a new episode, Nick Linton, head of Opella UK, discusses why community pharmacy should be seen as a core part of the prevention agenda.
Prostate Progress, a data-powered project to find better tests, treatments, and care for prostate cancer, is expanding via an alliance with Macmillan.
Sanofi's Infilbray has become the first drug to treat neurological symptoms of rare lysosomal storage disorder Type 3 Gaucher disease (GD3) in the US.
The FDA has approved Beren's Lembaz for Niemann-Pick disease type C, the first drug shown to extend survival in the ultra-rare inherited disorder.
At the eleventh hour, the White House has rescinded its nomination of Heidi Overton – a staunch Trump ally – to be FDA Commissioner.
Editor's Picks
Newsletters and Deep Dive
digital magazine